The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma.
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Kyrollis Attalla
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Samuel J. Murray
Travel, Accommodations, Expenses - Exelixis
 
Ying-Bei Chen
No Relationships to Disclose
 
Ritesh Kotecha
No Relationships to Disclose
 
Jeremy C. Durack
Stock and Other Ownership Interests - Adient Medical; Bronx Medical Center; Verix
Consulting or Advisory Role - Adient Medical; Verix
Patents, Royalties, Other Intellectual Property - Patent disclosures, provisionals submitted for instrument to analyze biopsy specimens (unrelated to the small renal masses topic). Patent holder for device related to x-ray imaging data collection (unrelated to small renal masses topic)....July 2008.
Travel, Accommodations, Expenses - Verix
Other Relationship - Society of Interventional Radiology Foundation
(OPTIONAL) Uncompensated Relationships - Society of Interventional Radiology Foundation
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
A. Ari Hakimi
No Relationships to Disclose
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AVEO; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; Merck; Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
Other Relationship - Bristol-Myers Squibb